Form 4: GoodRx Holdings Executive Reports Stock Transaction
Insider Transaction (Form 4)
Thomas (Tc) Chan, Chief Accounting Officer of GoodRx Holdings, Inc., reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 5,793 Class A Common Stock on October 15, 2026; holds 20,371 after (Direct).
- Tax/exercise-price withholding: disposed of 2,948 Class A Common Stock at $3.38 ($9,964) on October 15, 2026; holds 17,423 after (Direct).
- Option exercise/conversion: disposed of 5,793 Restricted Stock Unit on October 15, 2026; holds 52,132 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Thomas (Tc) Chan — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Class A Common Stock | 5,793 | — | — | 20,371 |
| 2026-10-15 | Tax/exercise-price withholding | Class A Common Stock | 2,948 | $3 | $10.0K | 17,423 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Unit | 5,793 | — | — | 52,132 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (5,793 shares) |
| 2026-10-15 | Tax/exercise-price withholding (2,948 shares) |
| 2026-10-15 | Option exercise/conversion (5,793 shares) |
Keywords
insider transaction, Form 4, GDRX, GoodRx Holdings, Inc., neutral, Thomas (Tc) Chan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.